anti-MOK Protein Kinase (MOK) Anticorps

MOK belongs to the MAP kinase superfamily. De plus, nous expédions MOK Protéines (2) et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
MOK 5891 Q9UQ07
MOK 362787  
MOK 26448 Q9WVS4
Comment commander chez anticorps-enligne
  • +33 (0)1 76 63 32 65
  • +33 (0)1 74 18 08 22
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top anti-MOK Anticorps sur anticorps-enligne.fr

Showing 10 out of 59 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Fournisseur Livraison Prix Détails
Humain Lapin Inconjugué IHC, ELISA, WB Western blot analysis of extracts from HepG2/COLO205/293 cells, using MOK Antibody. The lane on the right is treated with the synthesized peptide. Immunohistochemistry analysis of paraffin-embedded human brain tissue, using MOK Antibody. The picture on the right is treated with the synthesized peptide. 100 μg Connectez-vous pour afficher 6 to 8 Days
342,86 €
Détails
Humain Lapin Inconjugué IHC (p), WB Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining. BC = breast carcinoma. HC = hepatocarcinoma MOK Antibody (S392) (ABIN391783) western blot analysis in A549 cell line lysates (35 µg/lane).This demonstrates the MOK antibody detected the MOK protein (arrow). 400 μL Connectez-vous pour afficher 14 to 16 Days
335,24 €
Détails
Roussette (Chauve-souris) Lapin Inconjugué WB 50 μg Connectez-vous pour afficher 11 to 14 Days
653,02 €
Détails
Humain Lapin Inconjugué ICC, IF, IHC (p), WB WB Image Sample(30 μg of whole cell lysate) A:293T 10% SDS PAGE antibody diluted at 1:1000 ICC/IF Image Immunofluorescence analysis of methanol-fixed A549, using RAGE, antibody at 1:100 dilution. 100 μL Connectez-vous pour afficher 5 to 7 Days
357,24 €
Détails
Poulet Lapin Inconjugué WB 50 μg Connectez-vous pour afficher 11 to 14 Days
653,02 €
Détails
Humain Lapin Inconjugué IC, IF, IP, WB Immunofluorescent analysis of MOK staining in MDAMB231 cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 °C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue). Western blot analysis of MOK expression in Raji (A), MDAMB231 (B), A549 (C) whole cell lysates. 200 μL Connectez-vous pour afficher 11 to 13 Days
464,29 €
Détails
Humain Lapin Inconjugué ELISA, IHC, WB 100 μL Connectez-vous pour afficher 11 to 14 Days
565,71 €
Détails
Humain Lapin Inconjugué IHC (p), WB 100 μg Connectez-vous pour afficher 11 to 14 Days
600,64 €
Détails
Humain Lapin Inconjugué ELISA, IHC   100 μL Connectez-vous pour afficher 13 Days
154,33 €
Détails
Humain Lapin Biotin IHC, ELISA, WB   200 μL Connectez-vous pour afficher 11 to 14 Days
1.150,64 €
Détails

MOK Anticorps par réactivité, application, clonalité et conjugué

Attributs Application Hôte Clonalité Conjugué
Human , ,


, , , , ,
Rat (Rattus) , ,


Mouse (Murine) , ,


, , , ,

anti-MOK Anticorps mieux référencés

  1. Human Polyclonal MOK Primary Antibody pour IHC, ELISA - ABIN1534199 : Gaugler, Brouwenstijn, Vantomme, Szikora, Van der Spek, Patard, Boon, Schrier, Van den Eynde: A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma. dans Immunogenetics 1996 (PubMed)

Plus d’anticorps contre MOK partenaires d’interaction

Human MOK Protein Kinase (MOK) interaction partners

  1. our results suggest MOK promoter hypomethylation is a common event and contributes to MOK overexpression in acute myeloid leukemia (Montrer BCL11A Anticorps)

  2. The findings indicate a statistically significant association of p.Gly82Ser polymorphism in RAGE (Montrer AGER Anticorps) with DR in T2DM patients.

  3. the expressions of ICK/MAK (Montrer MAK Anticorps)/MOK proteins in the intestinal tract can be differentially and dynamically regulated, implicating a significant functional diversity within this group of protein kinases.

  4. Our results suggest that RAGE (Montrer AGER Anticorps) may be important in tumor invasion and could be a potential predictor for the prognosis of hepatocellular carcinoma patients.

  5. PBMNC from type 2 diabetics were more sensitive to innate immune stimulation with LPS (Montrer IRF6 Anticorps) and monoclonal agonist anti-TLR4 (Montrer TLR4 Anticorps) than were cells from ND. The actions of LPS (Montrer IRF6 Anticorps), anti-TLR4 (Montrer TLR4 Anticorps) and anti-RAGE (Montrer AGER Anticorps) potentiated the production of IL-6 (Montrer IL6 Anticorps) and TNF-alpha (Montrer TNF Anticorps) in both groups.

  6. The RAGE (Montrer AGER Anticorps) pathway may play an important role in STAT3 (Montrer STAT3 Anticorps) induction in glioma-associated macrophages and microglia, a process that may be mediated through S100B (Montrer S100B Anticorps).

  7. RAGE (Montrer AGER Anticorps) was demonstrated in all 8 yolk sac (Montrer ADCY10 Anticorps) tumors and 21 of 26 embryonal carcinomas. In yolk sac (Montrer ADCY10 Anticorps) tumors, RAGE (Montrer AGER Anticorps) reactivity was diffusely present throughout the tumors. In embryonal carcinomas, RAGE (Montrer AGER Anticorps) was identified only in yolk sac (Montrer ADCY10 Anticorps) components

  8. identification of MOK, a member of the mitogen-activated protein kinase (Montrer MAPK1 Anticorps) superfamily, as one of the genes induced by a caudal (Montrer CAD Anticorps)-related homeobox (Montrer Lbx1 Anticorps) transcription factor, Cdx2 (Montrer CDX2 Anticorps)

  9. May provide suitable targets for immunotherapy of renal cell carcinoma.

  10. Compared RAGE (Montrer AGER Anticorps) and PAX-2 (Montrer PAX2 Anticorps) staining in metastatic clear renal cell carcinoma.

Mouse (Murine) MOK Protein Kinase (MOK) interaction partners

  1. the expressions of ICK/MAK (Montrer MAK Anticorps)/MOK proteins in the intestinal tract can be differentially and dynamically regulated, implicating a significant functional diversity within this group of protein kinases.

  2. identification of MOK, a member of the mitogen-activated protein kinase (Montrer MAPK1 Anticorps) superfamily, as one of the genes induced by a caudal (Montrer CAD Anticorps)-related homeobox (Montrer PRRX1 Anticorps) transcription factor, Cdx2 (Montrer CDX2 Anticorps)

  3. RAGE (Montrer AGER Anticorps) inactivation inhibits the atherosclerosis through reducing oxLDL-induced pro-inflammatory responses and oxidative stress in hyperlipidaemia.

  4. Suppression of Egr-1 (Montrer EGR1 Anticorps) may contribute to the protective mechanisms underlying the beneficial impact of RAGE (Montrer AGER Anticorps) blockade or deletion in hepatic ischemia/reperfusion injury.

MOK profil antigène

Profil protéine

This gene belongs to the MAP kinase superfamily. The gene was found to be regulated by caudal type transcription factor 2 (Cdx2) protein. The encoded protein, which is localized to epithelial cells in the intestinal crypt, may play a role in growth arrest and differentiation of cells of upper crypt and lower villus regions. Multiple alternatively spliced transcript variants encoding different isoforms have been observed for this gene.

Gene names and symbols associated with anti-MOK Protein Kinase (MOK) Anticorps

  • MOK protein kinase (MOK) anticorps
  • MOK protein kinase (Mok) anticorps
  • serine/threonine kinase 30 (Stk30) anticorps
  • MOK anticorps
  • Rage anticorps
  • RAGE-1 anticorps
  • RAGE1 anticorps

Protein level used designations for anti-MOK Protein Kinase (MOK) Anticorps

MAPK/MAK/MRK overlapping kinase , renal cell carcinoma antigen , renal tumor antigen 1 , renal tumor antigen , MAPK/MAK/MRK/ overlapping kinase , MOK protein kinase , T/STK 30

GENE ID SPECIES
5891 Homo sapiens
362787 Rattus norvegicus
26448 Mus musculus
Fournisseurs de qualité sélectionnés pour anti-MOK (MOK) Anticorps
Avez-vous cherché autre chose?